• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recanalization before Thrombectomy in Tenecteplase vs. Alteplase-Treated Drip-and-Ship Patients.

作者信息

Seners Pierre, Caroff Jildaz, Chausson Nicolas, Turc Guillaume, Denier Christian, Piotin Michel, Aghasaryan Manvel, Alecu Cosmin, Chassin Olivier, Lapergue Bertrand, Naggara Olivier, Ferrigno Marc, Arquizan Caroline, Cho Tae-Hee, Narata Ana-Paula, Richard Sébastien, Bricout Nicolas, Mazighi Mikaël, Costalat Vincent, Gory Benjamin, Debiais Séverine, Consoli Arturo, Bracard Serge, Oppenheim Catherine, Mas Jean-Louis, Smadja Didier, Spelle Laurent, Baron Jean-Claude

机构信息

Neurology Department, Sainte-Anne Hospital and Paris Descartes University, INSERM U894, Paris, France.

Interventional Neuroradiology Department, Kremlin-Bicêtre Hospital, Kremlin-Bicêtre, France.

出版信息

J Stroke. 2019 Jan;21(1):105-107. doi: 10.5853/jos.2018.01998. Epub 2018 Dec 18.

DOI:10.5853/jos.2018.01998
PMID:30558399
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6372902/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6454/6372902/1fb67afbed33/jos-2018-01998f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6454/6372902/1fb67afbed33/jos-2018-01998f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6454/6372902/1fb67afbed33/jos-2018-01998f1.jpg

相似文献

1
Recanalization before Thrombectomy in Tenecteplase vs. Alteplase-Treated Drip-and-Ship Patients.替奈普酶与阿替普酶治疗静脉溶栓转运患者在取栓前再通情况的比较
J Stroke. 2019 Jan;21(1):105-107. doi: 10.5853/jos.2018.01998. Epub 2018 Dec 18.
2
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.替奈普酶与阿替普酶在缺血性脑卒中取栓前的比较。
N Engl J Med. 2018 Apr 26;378(17):1573-1582. doi: 10.1056/NEJMoa1716405.
3
Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke.急性缺血性卒中静脉溶栓后血管内血栓切除术的两种模式
JAMA Neurol. 2017 May 1;74(5):549-556. doi: 10.1001/jamaneurol.2016.5823.
4
Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.急性缺血性卒中：在延长时间窗内进行影像引导的替奈普酶治疗
Neurology. 2009 Mar 10;72(10):915-21. doi: 10.1212/01.wnl.0000344168.05315.9d.
5
Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.急性缺血性脑卒中患者可见颅内闭塞再通与临床、影像和血栓特征的关系。
JAMA. 2018 Sep 11;320(10):1017-1026. doi: 10.1001/jama.2018.12498.
6
Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials.替奈普酶与阿替普酶治疗急性冠状动脉综合征的安全性和有效性：一项随机试验的系统评价和荟萃分析
Arch Med Sci. 2016 Dec 1;12(6):1181-1187. doi: 10.5114/aoms.2016.58929. Epub 2016 Mar 31.
7
Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.达比加群酯逆转急性缺血性脑卒中患者静脉使用替奈普酶。
Stroke. 2020 May;51(5):1616-1619. doi: 10.1161/STROKEAHA.119.028327. Epub 2020 Mar 25.
8
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.替奈普酶与阿替普酶治疗急性缺血性脑卒中的比较（NOR-TEST）：一项 3 期、随机、开放标签、盲终点试验。
Lancet Neurol. 2017 Oct;16(10):781-788. doi: 10.1016/S1474-4422(17)30253-3. Epub 2017 Aug 2.
9
Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study.替奈普酶与血管内血栓切除术前的阿替普酶（EXTEND-IA TNK）：一项多中心、随机、对照研究。
Int J Stroke. 2018 Apr;13(3):328-334. doi: 10.1177/1747493017733935. Epub 2017 Sep 27.
10
Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials.替奈普酶与阿替普酶治疗急性缺血性脑卒中的比较：随机临床试验的成对和网络荟萃分析。
J Thromb Thrombolysis. 2018 Nov;46(4):440-450. doi: 10.1007/s11239-018-1721-3.

引用本文的文献

1
Tenecteplase compared to alteplase before mechanical thrombectomy enhances 1-h recanalization and reduces disability in large-vessel occlusion.在进行机械取栓前，替奈普酶与阿替普酶相比，可提高1小时再通率并降低大血管闭塞导致的残疾率。
J Neurol. 2025 Apr 9;272(5):324. doi: 10.1007/s00415-025-13084-2.
2
Emergency Department Workflow Times of Intravenous Thrombolysis with Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Prospective Cohort Study before and during the COVID-19 Pandemic.急性缺血性卒中中替奈普酶与阿替普酶静脉溶栓的急诊科工作流程时间：COVID-19大流行之前及期间的一项前瞻性队列研究
Cerebrovasc Dis Extra. 2025;15(1):102-109. doi: 10.1159/000543900. Epub 2025 Feb 3.
3

本文引用的文献

1
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.替奈普酶与阿替普酶在缺血性脑卒中取栓前的比较。
N Engl J Med. 2018 Apr 26;378(17):1573-1582. doi: 10.1056/NEJMoa1716405.
2
Increase in Endovascular Therapy in Get With The Guidelines-Stroke After the Publication of Pivotal Trials.关键试验发表后，指南中的血管内治疗在 Get With The Guidelines-Stroke 中的应用增加。
Circulation. 2017 Dec 12;136(24):2303-2310. doi: 10.1161/CIRCULATIONAHA.117.031097. Epub 2017 Oct 5.
3
Incidence and Predictors of Early Recanalization After Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.
Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial.
替奈普酶与阿替普酶治疗中等血管闭塞性缺血性卒中的疗效比较：阿替普酶与替奈普酶随机对照试验的二次分析
J Stroke. 2024 May;26(2):280-289. doi: 10.5853/jos.2023.03713. Epub 2024 May 30.
4
Arterial Recanalization During Interhospital Transfer for Thrombectomy.血管再通在院内转院取栓术中的应用。
Stroke. 2024 Jun;55(6):1525-1534. doi: 10.1161/STROKEAHA.124.046694. Epub 2024 May 16.
5
Tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis of randomized and non-randomized studies.替奈普酶与阿替普酶治疗急性缺血性脑卒中的比较：一项随机和非随机研究的系统评价和荟萃分析。
J Neurol. 2024 May;271(5):2309-2323. doi: 10.1007/s00415-024-12243-1. Epub 2024 Mar 4.
6
Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial.基于灌注成像选择的发病后 24 小时内的急性缺血性脑卒中患者使用替奈普酶溶栓治疗：伞状 CHABLIS-T Ⅱa 期随机临床试验。
Stroke Vasc Neurol. 2024 Nov 5;9(5):551-559. doi: 10.1136/svn-2023-002820.
7
Tenecteplase, 0.4 mg/kg, in Moderate and Severe Acute Ischemic Stroke: A Pooled Analysis of NOR-TEST and NOR-TEST 2A.替奈普酶 0.4mg/kg 治疗中度和重度急性缺血性脑卒中：NOR-TEST 和 NOR-TEST 2A 的汇总分析。
J Am Heart Assoc. 2023 Oct 17;12(20):e030320. doi: 10.1161/JAHA.123.030320. Epub 2023 Oct 13.
8
Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.替奈普酶与阿替普酶用于急性缺血性卒中静脉溶栓治疗的系统评价和Meta分析
Neurol Ther. 2023 Oct;12(5):1553-1572. doi: 10.1007/s40120-023-00530-4. Epub 2023 Aug 8.
9
The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.替奈普酶与阿替普酶静脉溶栓治疗急性缺血性脑卒中的有效性和安全性：系统评价和荟萃分析。
Neurol Sci. 2023 Sep;44(9):3005-3015. doi: 10.1007/s10072-023-06801-0. Epub 2023 Apr 15.
10
Different dosing regimens of Tenecteplase in acute ischemic stroke: A network meta-analysis of the clinical evidence.不同剂量替奈普酶治疗急性缺血性脑卒中：临床证据的网络荟萃分析。
Eur Stroke J. 2023 Mar;8(1):93-105. doi: 10.1177/23969873221129924. Epub 2022 Oct 13.
静脉溶栓后早期再通的发生率及预测因素：一项系统评价和Meta分析
Stroke. 2016 Sep;47(9):2409-12. doi: 10.1161/STROKEAHA.116.014181. Epub 2016 Jul 26.
4
Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.阿替普酶与替奈普酶治疗缺血性脑卒中溶栓（ATTEST）：一项 2 期、随机、开放标签、盲终点研究。
Lancet Neurol. 2015 Apr;14(4):368-76. doi: 10.1016/S1474-4422(15)70017-7. Epub 2015 Feb 26.
5
A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.替奈普酶与阿替普酶治疗急性缺血性脑卒中的随机试验。
N Engl J Med. 2012 Mar 22;366(12):1099-107. doi: 10.1056/NEJMoa1109842.
6
New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA.与重组人组织型纤溶酶原激活剂（TPA）相比，具有更高疗效和更低出血发生率的人组织型纤溶酶原激活剂（TPA）新变体。
Circulation. 1995 Nov 15;92(10):3032-40. doi: 10.1161/01.cir.92.10.3032.